Two-stent approach comparison for new bifurcation heart blockages
Part of Heart & circulation clinical trials.
This study compares two different ways of placing two drug-eluting stents for new (de novo) coronary artery blockages that split into two branches. It may help doctors choose the safest, most effective technique for patients with specific coronary anatomy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 19 or older.
- You have a new coronary (heart) artery blockage that can be treated with drug-eluting stents.
- Your blockage is a “bifurcation” pattern (it splits into two branches) matching one of these specific layouts: 1,1,1 or 1,0,1 or 0,1,1.
- The side-branch of your artery is at least 2.5 mm wide (based on the doctor’s estimate).
- You can commit to follow-up visits for about 1 year after starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to treat a narrowed heart artery where a smaller branch vessel is also blocked. One approach uses a drug-coated balloon on the side branch, while the other places a second stent. The goal is to see which method works better for patients like you.
This study compares two ways to open blocked heart arteries: one uses a balloon coated with medicine, and the other uses a small mesh tube (stent) that releases medicine. The goal is to see which works better for people with chest pain or a recent heart attack.
This trial compares two ways to open a specific type of heart blockage that involves both a main artery and a side branch. It tests whether using a drug-coated balloon (“hybrid strategy”) works as well as using a planned two-stent approach (“stepwise provisional strategy”).
This trial compares two treatments for new blockages in heart arteries: a drug-coated balloon (a tiny balloon that delivers medicine) versus a drug-eluting stent (a small mesh tube that releases medicine). The study hopes to see which approach keeps the artery open longer and is safer over time.
This trial tests a new way to treat complex blockages in heart arteries where a side branch is also narrowed. It uses a drug-coated balloon to open the side branch, aiming to improve blood flow and reduce the need for repeat procedures.
This trial compares two ways to open a blocked artery that splits into two branches (a bifurcation): using a balloon coated with medicine (drug-coated balloon, or DCB) versus a drug-eluting stent (DES). The goal is to see which approach works better for patients with this type of blockage.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.